Literature DB >> 2492080

Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch.

B Knapp1, E Hundt, U Nau, H A Küpper.   

Abstract

Two short DNA segments were isolated by screening of a lambda gt11 library from Plasmodium falciparum schizont cDNA with an antiserum against the 140 kDa protein, which confers protective immunity to monkeys. The segments were used to identify a genomic fragment which carries the entire coding sequence for a protein of 113 kDa characterized by a stretch of serine residues (SERP I). We present the complete nucleotide and deduced amino acid sequence as well as the structure of the SERP I gene. The gene consists of four exons interrupted by three short introns located at the amino-terminal half. Exon 1 and the first part of exon 2 code for hydrophobic amino acids of a putative signal sequence. Exon 2 contains two repetitive segments, the first encoding six glycine rich octapeptides and a second region coding for 37 consecutive serine residues. Southern blot analysis demonstrated the conservation of the SERP I gene in four different parasite strains. SERP I could be localized in the parasitophorous vacuole and in the surrounding membranes. We discuss the relationship of this protein to the recently described P126 polypeptide and the possible role of this antigen as a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492080     DOI: 10.1016/0166-6851(89)90131-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  24 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

2.  In vitro biosynthesis and in vivo processing of the major microneme antigen of Sarcocystis muris cyst merozoites.

Authors:  H Klein; H Mehlhorn; W Rüger
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

3.  Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins.

Authors:  B Knapp; E Hundt; B Enders; H A Küpper
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant.

Authors:  J Inselburg; I C Bathurst; J Kansopon; P J Barr; R Rossan
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

6.  Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.

Authors:  Joanne E McCoubrie; Susanne K Miller; Tobias Sargeant; Robert T Good; Anthony N Hodder; Terence P Speed; Tania F de Koning-Ward; Brendan S Crabb
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

7.  Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Authors:  J A Tine; V Conseil; P Delplace; C De Taisne; D Camus; E Paoletti
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Conservation of antigen components from two recombinant hybrid proteins protective against malaria.

Authors:  B Knapp; U Nau; E Hundt
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 9.  Malarial proteases and host cell egress: an 'emerging' cascade.

Authors:  Michael J Blackman
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  LISP1 is important for the egress of Plasmodium berghei parasites from liver cells.

Authors:  Tomoko Ishino; Bertrand Boisson; Yuki Orito; Céline Lacroix; Emmanuel Bischoff; Céline Loussert; Chris Janse; Robert Ménard; Masao Yuda; Patricia Baldacci
Journal:  Cell Microbiol       Date:  2009-05-06       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.